Jump to content
Powered by
  • BIOPRO BW
  • Healthcare industry
  • Bioeconomy

Healthcare industry

Main navigation

  • Start page
  • Healthcare industry BW

    Healthcare industry BW

    Close
    • At a glance
    • The biotechnology sector
    • Medical technology
    • The pharmaceutical industry
    • Training & university education
    • Company foundation
    • Infrastructure
    • Clusters & Networks
  • Articles

    Articles

    Close
    • Latest news
    • Selected press releases
    • Dossiers
    • Red biotechnology
    • Medical technology
    • Pharmaceutics
    • Diagnostics
    • Basic research
    • Selected publications
  • Events

    Events

    Close
  • Databases

    Databases

    Close
    • Funding
    • Healthcare industry database
    • Research institutions
  • BIOPRO services

    BIOPRO services

    Close
    • BIOPRO services and offers
    • Contacts
    • Information channels
  • de
  • en
Show menu

You are here:

  1. Home
  2. Search
Show:Results per page
  • 25Show results
  • 50Show results
  • 75Show results

Search Results

  • Event - 01/07/2022

    BadenCampus Health Community Meeting

    Breisach, Registration deadline: 24/06/2022, Meet & Match
    https://www.gesundheitsindustrie-bw.de/en/event/badencampus-health-community-meeting
  • Event - 30/09/2022

    Start-Up BW Summit 2022

    Stuttgart, Registration deadline: 23/05/2022, Messe
    https://www.gesundheitsindustrie-bw.de/en/event/start-bw-summit-2022
  • Product testing under real conditions - 11/05/2022 The photo shows a modern hospital room with a nursing bed.

    INSPIRE Living Lab: a bridge between industry and the clinic

    Coming up with innovative ideas and products in the medical care area is highly relevant not only for the further development of Baden-Württemberg as a health region, but also for improving healthcare itself. However, bridging the gap between industry and the clinic often proves difficult. To drive this process forward, the INSPIRE Living Lab was opened at the University Medical Centre Mannheim in 2021.

    https://www.gesundheitsindustrie-bw.de/en/article/news/inspire-living-lab-bridge-between-industry-and-clinic
  • Company profile: medicalvalues GmbH - 05/05/2022 Laptop mit einer Software-Oberfläche, die in Weiß und teilweise in Violet gehalten ist.

    medicalvalues – best possible diagnostics thanks to AI

    The Karlsruhe-based start-up medicalvalues GmbH wants to use its platform to bring together different clinical data sets and thus enable comprehensive medical diagnostics. Artificial intelligence featuring innovative diagnostic algorithms is used to evaluate the data and generate new insights for laboratories and hospitals.

    https://www.gesundheitsindustrie-bw.de/en/article/news/medicalvalues-best-possible-diagnostics-thanks-ai
  • Event - 13/10/2022 - 14/10/2022

    HealthTech Innovation Days

    Paris (France), Kongress/Symposium
    https://www.gesundheitsindustrie-bw.de/en/event/healthtech-innovation-days
  • Event - 10/05/2022 - 11/05/2022

    LSX World Congress

    London (England), Kongress/Symposium
    https://www.gesundheitsindustrie-bw.de/en/event/lsx-world-congress
  • Event - 17/05/2022

    International Clinical Trials Day 2022 (ICTD)

    Berlin and Online, Kongress/Symposium
    https://www.gesundheitsindustrie-bw.de/en/event/international-clinical-trials-day-2022-ictd
  • Event - 05/07/2022 - 06/07/2022

    FORUM Science & Health – Medicine of Future

    Fürstenfeldbruck, Kongress/Symposium
    https://www.gesundheitsindustrie-bw.de/en/event/forum-science-health-medicine-future
  • Press release - 28/04/2022

    Tumors on withdrawal: Amino acid deficiency shrinks childhood tumors

    Certain childhood tumors have an extreme need for amino acids. Scientists at the Hopp Children's Cancer Center Heidelberg (KiTZ), the German Cancer Research Center (DKFZ), the University of Heidelberg, and HI-STEM* gGmbH have now discovered the molecular mechanisms underlying this and how the cancer cells could be turned off.

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/tumors-withdrawal-amino-acid-deficiency-shrinks-childhood-tumors
  • Press release - 26/04/2022

    BioLabs Heidelberg announces key partnership and new members in its vibrant life-science community

    BioLabs, the premier developer and operator of life science coworking spaces, is thrilled to welcome its first three inaugural tenants to its Heidelberg location: Anavo Therapeutics, faCellitate, and Phialogics. BioLabs has announced BioRN, the leading non-profit membership network in the Rhine-Neckar region, as its Founding Partner. This partnership will enable BioLabs to adapt their business model to the German biotech system.

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/biolabs-heidelberg-announces-key-partnership-and-new-members-its-vibrant-life-science-community
  • Event - 01/11/2022 - 04/11/2022

    Web Summit 2022

    Lisboa (Portugal), Kongress/Symposium
    https://www.gesundheitsindustrie-bw.de/en/event/web-summit-2022
  • Event - 10/05/2022

    Introducing the Global Health EDCTP3 Joint Undertaking

    Paris (France) and online, Informationsveranstaltung
    https://www.gesundheitsindustrie-bw.de/en/event/introducing-global-health-edctp3-joint-undertaking
  • Press release - 25/04/2022

    Reprogrammed macrophages promote spread of breast cancer

    Metastatic breast cancer cells abuse macrophages, a type of immune cell, to promote the settlement of cancer metastases in the lungs. The reprogrammed macrophages stimulate blood vessel cells to secrete a cocktail of metastasis-promoting proteins that are part of the so-called metastatic niche.

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/reprogrammed-macrophages-promote-spread-breast-cancer
  • Event - 24/05/2022

    Fostering science-industry collaboration: 2nd Bridging the Gap Workshop

    Online, Online Seminar
    https://www.gesundheitsindustrie-bw.de/en/event/fostering-science-industry-collaboration-2nd-bridging-gap-workshop
  • Peptide-based COVID-19 vaccine - 21/04/2022 A 96-well analysis plate with depressions of varying darkness is shown, held up by two gloved hands.

    CoVac-1: T-cell activator against COVID-19

    Current vaccines against COVID-19 aim at forming neutralising antibodies that prevent the virus from penetrating the host cells. Since people with impaired B-cell immune responses – which can also occur in cancer or autoimmune diseases – are not able to do this, researchers at the University of Tübingen have developed the peptide-based T-cell activator CoVac-1, which promises broad and long-term immunity.

    https://www.gesundheitsindustrie-bw.de/en/article/news/covac-1-t-cell-activator-against-covid-19
  • Event - 26/04/2022 - 28/04/2022

    DMEA 2022

    Berlin, Kongress/Symposium
    https://www.gesundheitsindustrie-bw.de/en/event/dmea-2022
  • Press release - 13/04/2022

    Emmy Noether funding for research into drug resistance of blood cancer

    The Deutsche Forschungsgemeinschaft (DFG, German Research Foundation) is funding a new Emmy Noether junior research group at the DKFZ for six years with a total of around 2 million euros. The scientists and doctors, who are part of the Clinical Cooperation Unit for Pediatric Leukemia at the KiTZ, are using a new procedure to investigate how cancer cells manipulate the formation of proteins to become resistant to cancer drugs.

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/emmy-noether-funding-research-drug-resistance-blood-cancer
  • Event - 16/05/2022

    Health Data Futures – Launch Event 2022

    Online, Registration deadline: 15/05/2022, Informationsveranstaltung
    https://www.gesundheitsindustrie-bw.de/en/event/health-data-futures-launch-event-2022
  • Press release - 12/04/2022

    Technology transfer award for PCR rapid test device for infection diagnostics

    Spindiag GmbH, together with the University of Freiburg and the Hahn-Schickard-Gesellschaft für angewandte Forschung e.V., was awarded the Technology Transfer Prize 2020 from the German Physical Society (DPG) on April 09, 2022 for the development of the PCR-based rapid test system Rhonda.

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/technology-transfer-award-pcr-rapid-test-device-infection-diagnostics
  • Funding

    EIC Accelerator

    Funding programme, Funded by: European Commission, Submission deadline: 15/06/2022
    https://www.gesundheitsindustrie-bw.de/en/database/funding/eic-accelerator
  • Funding

    EIC Pathfinder Challenges

    Funding programme, Funded by: European Commission, Submission deadline: 19/10/2022
    https://www.gesundheitsindustrie-bw.de/en/database/funding/eic-pathfinder-challenges
  • COVIC-19 clinical trial - 07/04/2022 Schematic showing how the clinical trial will be performed.

    Convalescent plasma for COVID-19 therapy: clinical trial should bring clarity

    Does it help to treat COVID-19 sufferers with antibodies from people who have recovered from the disease? It seems an obvious idea and has been tested thousands of times. However, there is not yet enough evidence to prove the clinical efficacy of treating COVID-19 patients with convalescent plasma. The transfusion physician Prof. Dr. Hubert Schrezenmeier from Ulm is planning to carry out a follow-up clinical trial to find the missing evidence.

    https://www.gesundheitsindustrie-bw.de/en/article/news/convalescent-plasma-covid-19-therapy-clinical-trial-should-bring-clarity
  • Event - 24/05/2022 - 25/05/2022

    EIT Health Summit 2022

    Stockholm (Sweden), Kongress/Symposium
    https://www.gesundheitsindustrie-bw.de/en/event/eit-health-summit-2022
  • Press release - 01/04/2022

    FDA approval for targeted radioligand therapy for treatment of metastatic prostate cancer

    On March 23, 2022, the U.S. Food and Drug Administration (FDA) granted approval to the first targeted radioligand therapy against metastatic prostate cancer based on a joint patent of the German Cancer Research Center (DKFZ) and the University of Heidelberg. The agent significantly improves the chances of survival for those affected.

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/fda-approval-targeted-radioligand-therapy-treatment-metastatic-prostate-cancer
  • Press release - 30/03/2022

    CureVac and GSK Start Clinical Development of Second-Generation COVID-19 Vaccine Candidate, CV2CoV

    CureVac N.V. a global biopharmaceutical company developing a new class of transformative medicines based on messenger ribonucleic acid (“mRNA”), today announced that the first participant was dosed in a Phase 1 study of COVID-19 second-generation mRNA vaccine candidate, CV2CoV, developed in collaboration with GSK.

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/curevac-and-gsk-start-clinical-development-second-generation-covid-19-vaccine-candidate-cv2cov

Page 1 / 115

sb_search.block.search_result.other.pages

  • 1
  • 2
  • 3
  • 4
  • 5
  • …
  • 115
  • eine Seite zurück
  • Extend search to all portals
  • Search the Healthcare industry database
  • Search the Research institutions
Search terms
Portal
Information type
  • Type
    Event date
    From
    To
  • Type
  • Publication date
    Topics
    Topics
  • Publication date
Reset

Footer navigation

  • Healthcare industry BW
    • At a glance
    • The biotechnology sector
    • Medical technology
    • The pharmaceutical industry
    • Training & university education
    • Company foundation
    • Infrastructure
    • Clusters & Networks
  • Articles
    • Latest news
    • Selected press releases
    • Dossiers
    • Red biotechnology
    • Medical technology
    • Pharmaceutics
    • Diagnostics
    • Basic research
    • Selected publications
  • Events
  • Databases
    • Funding
    • Healthcare industry database
    • Research institutions
  • BIOPRO services
    • BIOPRO services and offers
    • Contacts
    • Information channels
  • Project pages
    • Telemedicine BW
    • MDR & IVDR
  • Portals
    • BIOPRO BW
    • Healthcare industry
    • Bioeconomy
  • To top

stay informed

Subscribe to newsletter

Social Media

  • Xing
  • Twitter
  • LinkedIn
  • Rss
  • Privacy statement
  • Legal notice
  • Sitemap
  • Contact
© 2022
Website address: https://www.gesundheitsindustrie-bw.de/en/search